DBV Technologies | DBVT - Acreedores Comerciales

Precio De Mercado
20.59
Cambio Diario
-0.81 -3.79%
Mensual
-0.58%
Anual
181.28%
Q2 Expectativa
20.10




Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amarin USD 45.36M 8.64M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
DBV Technologies USD 39.82M 972K 2025-09
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Galectin Therapeutics USD 3.7M 99K 2024-06
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Insmed USD 79.91M 316K 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
United Therapeutics USD 7.1M 460.9M 2025-12